SEC Form 4 · accession 0001179110-18-004490
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Mar 16, 2018
Accepted (ET)
Mar 16, 2018 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2018 | M | 25,000 | $4.29 | A | 209,987 | D | |
| Common StockF1 | Mar 16, 2018 | S | 25,000 | $12.0162 | D | 184,987 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.29 | Mar 16, 2018 | M | 25,000 | D | Jan 1, 2010 | Jan 1, 2019 | Common Stock | 25,000 | 113,518 | D |
Explanation of responses
- F1Weighted average price of shares sold.
- F2Exercisable in four equal installments over four years starting on the first year anniversary of the grant.